As with all GLP-1 therapies, there are important safety considerations: Not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) May cause nausea, vomiting, diarrhea , especially during dose titration Monitor for signs of pancreatitis , gallbladder issues, or allergic reactions Not indicated for patients with Type 1 diabetes or those with severe gastrointestinal disorders Regular follow-ups, lab monitoring, and dose adjustments are part of the DrWell Methodology to ensure safe, effective outcomes
Pentadecapeptide BPC 157 cream improves burn-wound healing and suppresses delayed-type hypersensitivity reactions
Filter both drinking and shower water
Whatever size syringe you get, you can use this video to figure out how to draw up the proper dose of the hormone
All research compounds are stored under appropriate storage conditions before shipment